Pearce Samantha has filed 23 insider transactions across 1 company since January 2023.
Most recent transaction: a tax payment of 2503 shares of Jazz Pharmaceuticals plc ($JAZZ) on March 05, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | F | Ordinary Shares | 2503 | $188.69 | 50,272.0000 | 61,606,000 | 4.74% | 0.00% |
| Feb. 26, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | A | Ordinary Shares | 9782 | $0.00 | 52,775.0000 | 61,606,000 | 22.75% | 0.02% |
| Jan. 16, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | A | Ordinary Shares | 3637 | $0.00 | 44,592.0000 | 61,606,000 | 8.88% | 0.01% |
| Jan. 16, 2026 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | F | Ordinary Shares | 1599 | $171.16 | 42,993.0000 | 61,606,000 | 3.59% | 0.00% |
| Aug. 5, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | F | Ordinary Shares | 577 | $116.10 | 40,815.0000 | 66,007,000 | 1.39% | 0.00% |
| March 5, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | D | Ordinary Shares | 1905 | $138.95 | 41,226.0000 | 66,007,000 | 4.42% | 0.00% |
| Feb. 27, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | A | Ordinary Shares | 5778 | $0.00 | 43,131.0000 | 66,007,000 | 15.47% | 0.01% |
| Feb. 27, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | A | Ordinary Shares | 11941 | $0.00 | 37,353.0000 | 66,007,000 | 46.99% | 0.02% |
| Jan. 17, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | F | Ordinary Shares | 1365 | $122.62 | 25,412.0000 | 66,007,000 | 5.10% | 0.00% |
| Jan. 17, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | A | Ordinary Shares | 2533 | $0.00 | 26,777.0000 | 66,007,000 | 10.45% | 0.00% |
| Aug. 2, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | EVP, Chief Commercial Officer | A | Ordinary Shares | 6996 | $0.00 | 24,078.0000 | 72,066,000 | 40.96% | 0.01% |
| March 5, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | F | Ordinary Shares | 2474 | $117.53 | 16,922.0000 | 72,066,000 | 12.76% | 0.00% |
| March 1, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | A | Ordinary Shares | 5065 | $0.00 | 19,396.0000 | 72,066,000 | 35.34% | 0.01% |
| Jan. 17, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | F | Ordinary Shares | 1038 | $119.13 | 14,331.0000 | 72,066,000 | 6.75% | 0.00% |
| Jan. 17, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | A | Ordinary Shares | 2210 | $0.00 | 15,369.0000 | 72,066,000 | 16.79% | 0.00% |
| March 5, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | F | Ordinary Shares | 2020 | $142.78 | 13,159.0000 | 62,539,000 | 13.31% | 0.00% |
| March 3, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | A | Ordinary Shares | 3870 | $0.00 | 15,179.0000 | 62,539,000 | 34.22% | 0.01% |
| Feb. 2, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | S | Ordinary Shares | 531 | $157.26 | 11,309.0000 | 62,539,000 | 4.48% | 0.00% |
| Feb. 2, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | M | Ordinary Shares | 531 | $109.45 | 11,840.0000 | 62,539,000 | 4.70% | 0.00% |
| Feb. 2, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | M | Non-Qualified Stock Option (right to buy) | 531 | $0.00 | 6,907.0000 | 62,539,000 | 7.14% | 0.00% |
| Jan. 3, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | S | Ordinary Shares | 531 | $159.59 | 11,309.0000 | 62,539,000 | 4.48% | 0.00% |
| Jan. 3, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | M | Non-Qualified Stock Option (right to buy) | 531 | $0.00 | 7,438.0000 | 62,539,000 | 6.66% | 0.00% |
| Jan. 3, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Pearce Samantha | SVP, Head of Europe & Internat | M | Ordinary Shares | 531 | $109.45 | 11,840.0000 | 62,539,000 | 4.70% | 0.00% |